Innovative Research Award

The Innovative Research Award recognizes researchers whose scholarly contributions have significantly advanced scientific understanding through sustained research productivity, interdisciplinary investigation, and measurable academic impact. Mohammad Mehdi Ommati has established a substantial research profile within neuropharmacology, contributing to experimental and translational investigations that have expanded knowledge regarding neurological mechanisms, pharmacological interventions, oxidative stress, and disease-related molecular pathways.[1]

Abstract

This academic recognition article examines the research achievements of Mohammad Mehdi Ommati in the field of neuropharmacology. With 158 indexed publications, 5,514 citations, and an h-index of 40, the researcher’s scholarly record demonstrates sustained productivity and broad scientific influence. The body of work reflects an emphasis on pharmacological mechanisms, experimental neuroscience, cellular protection, toxicological evaluation, and translational applications relevant to neurological disorders. These contributions provide a strong foundation for recognition within the Innovative Research Award category.[1]

Keywords

• Neuropharmacology
• Oxidative Stress
• Experimental Neuroscience
• Pharmacological Mechanisms
• Translational Research
• Neuroprotection

Introduction

Neuropharmacology represents a multidisciplinary scientific field that integrates neuroscience, pharmacology, molecular biology, and medicine to understand interactions between pharmaceutical agents and the nervous system. Contemporary research in this discipline contributes to the development of therapeutic strategies for neurodegenerative diseases, neurological injuries, psychiatric disorders, and toxicological conditions.[2]

Within this scientific environment, researchers who successfully combine laboratory investigation with clinically relevant applications play an important role in translating fundamental discoveries into therapeutic innovations. Mohammad Mehdi Ommati’s research portfolio reflects this translational perspective through a substantial body of peer-reviewed publications and measurable scientific impact.[1]

Research Profile

The research profile of Mohammad Mehdi Ommati demonstrates long-term engagement in biomedical and neurological investigations. Bibliometric indicators reveal a productive academic career characterized by high publication output and extensive citation activity. Such indicators are commonly used to evaluate scholarly productivity, research visibility, and scientific influence within academic communities.[1]

• 158 indexed publications.
• 5,514 citations.
• An h-index of 40.
• Primary specialization in neuropharmacology.
• Academic affiliation with the School of Medicine, Linyi University, China.

Research Contributions

The research contributions associated with Mohammad Mehdi Ommati encompass several interconnected scientific domains that contribute to the understanding of neurological health and disease.[1]

• Investigation of neuroprotective mechanisms associated with pharmacological compounds.
• Research into oxidative stress and cellular damage pathways.
• Experimental evaluation of therapeutic interventions in neurological models.
• Analysis of toxicological processes affecting neuronal function.
• Translation of laboratory findings into clinically relevant research frameworks.

Publications

A publication record exceeding one hundred and fifty peer-reviewed documents indicates consistent scientific activity across multiple research themes. Publication productivity in neuropharmacology frequently reflects collaborative investigation, methodological diversity, and sustained engagement with emerging biomedical challenges.[1]

Representative publication themes include neurotoxicity, antioxidant mechanisms, pharmacological regulation, neurodegenerative disease models, and translational neuroscience. Numerous studies within these categories are supported by internationally recognized publication databases and indexed literature.[3]

Research Impact

Research impact extends beyond publication quantity and includes citation performance, knowledge dissemination, scientific influence, and translational relevance. Citation counts exceeding 5,500 indicate that the researcher’s work has been frequently referenced by the scientific community, suggesting substantial engagement with the published findings.[1]

The h-index of 40 further supports the interpretation that a significant proportion of published studies have generated measurable academic influence. Bibliometric indicators should be interpreted alongside research quality, innovation, methodological rigor, and contributions to scientific advancement.[2]

Award Suitability

Several factors support the suitability of Mohammad Mehdi Ommati for recognition within the Innovative Research Award category.[1]

1. Demonstrated excellence in neuropharmacological research.
2. Extensive publication productivity.
3. Strong citation performance and scholarly visibility.
4. Evidence of interdisciplinary and translational investigation.
5. Contributions that align with the objectives of scientific recognition programs.

Conclusion

The academic record of Mohammad Mehdi Ommati reflects sustained scientific productivity, significant citation impact, and meaningful contributions to neuropharmacological research. Through experimental investigation and translational scholarship, the researcher has contributed to advancing knowledge related to neurological disorders and therapeutic interventions. These achievements support recognition through the Innovative Research Award presented by the World Neuroscientists Awards program.[1]

External Links

• ORCID Profile
• Scopus Author Profile
• World Neuroscientists Awards

References

1. Elsevier. (n.d.). Scopus author details: Mohammad Mehdi Ommati, Author ID 55696276900. Scopus.
   https://www.scopus.com/pages/authors/55696276900
2. Brunton, L., Hilal-Dandan, R., & Knollmann, B. (2018). Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
   https://doi.org/10.1036/0071422803
3. National Center for Biotechnology Information. (n.d.). Neuropharmacology literature and indexed biomedical publications.
   https://pubmed.ncbi.nlm.nih.gov/